Watch INBX. Know when insiders buy.
One email the day a filing lands. Free.
INBX
Inhibrx Biosciences, Inc.
114.34
−6.83 −5.64%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
80
PASS · insiders 100, shorts 60
Insiders, 90 days
+$3.5M
net buying · 8 buys, 0 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.7BP/E —DIV YIELD —FCF YIELD -7.84%REV TTM —NET INCOME −$138.2MNET DEBT $42.9M52W 26.53 – 141.84SEC XBRL · TTM TO Invalid Date
Insider trading
+$3.5M
Net, 90 days
8 / 0
Buys / sells, 90 days
3
Distinct buyers · cluster
$3.5M
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8 | Sep 8 | Kayyem Jon Faiz · Director | Buy | 5,000 | $113.52 | $568K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 9,681 | $112.28 | $1.1M |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 1,219 | $111.88 | $136K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 500 | $108.23 | $54K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 1,100 | $107.12 | $118K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 6,605 | $100.64 | $665K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 5,895 | $99.29 | $585K |
| Sep 8 | Sep 8 | FORSYTH DOUGLAS · Director | Buy | 2,500 | $114.65 | $287K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.